Cancer Genetics and Epigenetics 2024, Vol.12, No.6, 329-345 http://medscipublisher.com/index.php/cge 342 References Agirre X., Vilas-Zornoza A., Jiménez-Velasco A., Martín-Subero J.I., Cordeu L., Gárate L., José-Enériz E.S., Abizanda G., Rodríguez-Otero P., Fortes P., Rifón J., Bandrés E., Calasanz M.J., Martín V., Heiniger A., Torres A., Siebert R., Román-Gómez J., and Prósper, F., 2009, Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia, Cancer Research, 69(10): 4443-4453. https://doi.org/10.1158/0008-5472.CAN-08-4025 PMID: 19435910 Alshamrani A.I., 2020, Roles of microRNAs in ovarian cancer tumorigenesis: two decades later, what have we learned? Frontiers in Oncology, 10: 1084. https://doi.org/10.3389/fonc.2020.01084 PMID: 32850313 PMCID: PMC7396563 Anastasiadou, E., Jacob L.S., and Slack, F., 2017, Non-coding RNA networks in cancer, Nature Reviews Cancer, 18(1): 5-18. https://doi.org/10.1038/nrc.2017.99 PMID: 29170536 PMCID: PMC6337726 Braga E.A., Fridman M.V., Moscovtsev A.A., Filippova E.A., Dmitriev A.A., and Kushlinskii N.E., 2020, LncRNAs in ovarian cancer progression, metastasis, and Main pathways: ceRNA and alternative mechanisms, International Journal of Molecular Sciences, 21(22): 8855. https://doi.org/10.3390/ijms21228855 PMID: 33238475 PMCID: PMC7700431 Chatterjee B., Ghosh K., and Kanade S.R., 2019, Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21CIP1 in human breast cancer cell lines, BioFactors, 45(5): 818-829. https://doi.org/10.1002/biof.1544 PMID: 31317586 Chen M.Y., Lei N.J., Tian W.J., Li Y., and Chang L., 2022, Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics, Therapeutic Advances in Medical Oncology, 14: 17588359221118010. https://doi.org/10.1177/17588359221118010 PMID: 35983027 PMCID: PMC9379276 Cheng Y., He C., Wang M.N., Ma X.L., Mo F., Yang S.Y., Han J.H., and Wei X.W., 2019, Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials, Signal Transduction and Targeted Therapy, 4: 62. https://doi.org/10.1038/s41392-019-0095-0 PMID: 31871779 PMCID: PMC6915746 Dai Z.Y., Jin, S., Luo, H., Leng, H., and Fang, J., 2021, LncRNA HOTAIR regulates anoikis-resistance capacity and spheroid formation of ovarian cancer cells by recruiting EZH2 and influencing H3K27 methylation, Neoplasma, 68(3): 509-518. https://doi.org/10.4149/neo_2021_201112N1212 PMID: 33502891 Farooqi A.A., Fayyaz S., Poltronieri P., Calin G., and Mallardo M., 2020, Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs, Seminars in Cancer Biology, 83: 197-207. https://doi.org/10.1016/j.semcancer.2020.07.013 PMID: 32738290 Ferreira H.J., and Esteller M., 2018, Non-coding RNAs, epigenetics, and cancer: tying it all together, Cancer and Metastasis Reviews, 37: 55-73. https://doi.org/10.1007/s10555-017-9715-8 Gao Y., Meng H., Liu S.P., Hu J.J., Zhang Y.M., Jiao T.T., Liu Y.J., Ou J., Wang D., Yao L., Liu S.R., and Hui N., 2015, LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b, Human Molecular Genetics, 24(3): 841-852. https://doi.org/10.1093/hmg/ddu502 PMID: 25292198 Gelato K.A., Adler D., Ocker M., and Haendler B., 2016, Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs, Expert Opinion on Therapeutic Targets, 20(7): 783-799. https://doi.org/10.1517/14728222.2016.1134490 PMID: 26799480 Li H.X., and Li J.H., 2024, The potential of RNA interference in cervical cancer therapy, Cancer Genetics and Epigenetics, 12(4): 182-193. https://doi.org/10.5376/cge.2024.12.0020 Huang D.Y,, Cui L.Q., Ahmed S., Zainab F., Wu Q.H., Wang X., and Yuan Z.H., 2019, An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 123: 574-594. https://doi.org/10.1016/j.fct.2018.10.052 PMID: 30408543 Hussen B.M,, Hidayat H.J,, Salihi A., Sabir D.K., Taheri M., and Ghafouri-Fard S., 2021, MicroRNA: a signature for cancer progression, Biomedicine and Pharmacotherapy, 138: 111528. https://doi.org/10.1016/j.biopha.2021.111528
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==